ArticleFrontiers in oncology2025

Efficacy and safety of biosimilar trastuzumab (HLX02) in patients with HER2-positive advanced breast cancer: a retrospective real-world analysis.

Xuan Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.